A Randomized Controlled Trial to evaluate the Effectiveness of Mobile App (CANMET)Based Interventions on Metabolic Syndrome and Treatment Adherence among Adult Oncology Patients Receiving Systemic Anticancer Treatment in IRCH, AIIMS New Delhi.

This study is conducted for early identification of metabolic disorders in cancer patients who are in the initial period of chemotherapy, as metabolic syndrome will interfere with their prognosis and survival. If metabolic syndromes are identified during their initial treatment period of chemotherapy, with proper interventions and adequate treatment adherence measures, we can improve their long-term health and quality of life of cancer survivors. There are so many studies on cancer survivors, but very few studies on the active treatment period of chemotherapy and metabolic syndrome interventions. The CANMET App is a mobile app-based intervention on metabolic syndrome and treatment adherence , which helps the adult oncology patients to an improved, sustained period of survivorship. An RCT is the most rigorous method to determine if the CANMET APP is truly effective over standard care, justifying its widespread adoption and integration into the national care protocol.